Department of Family and Community Medicine, University of California San Francisco, USA.
Am J Manag Care. 2011;17(8):577-83.
To determine whether offering home fecal immunochemical tests (FITs) to eligible patients during a high volume influenza vaccination clinic could lead to increased colorectal cancer screening (CRCS) rates in a managed care setting.
Observational study.
During influenza vaccination clinics in 2008, trained staff provided FITs to patients who were eligible for CRCS (FLU-FIT group) (FLU indicates influenza vaccine). Screening outcomes for this cohort of patients were compared with those of a similar group of influenza clinic attendees who were not exposed to the intervention (FLUonly group).
Among eligible participants in the FLU-only group (N = 4653), 13.7% completed FIT within 90 days of their influenza vaccine, and in the FLU-FIT group (N = 2812), 30.3% completed FIT (P <.0001). In the FLU-FIT group, 1447 (51.4%) were provided with a FIT kit, and 653 (45.1%) of these patients completed a FIT kit within 90 days. In multivariate analyses, FLU-FIT group participants were significantly more likely to complete FITs compared with FLU-only group participants (Odds Ratio = 2.76 [95% confidence interval, 2.45-3.11]). Overall, the CRCS rate for the FLU-only group increased from 51.5% to 56.3% (increase of 4.8 percentage points), compared with an increase from 49.2% to 63.2% (increase of 14.0 percentage points) in the FLU-FIT group (P lt;.0001 for change difference).
The FLU-FIT Program is feasible to implement in a high volume influenza vaccination clinic conducted in a managed care setting and increases colorectal cancer screening activity among eligible influenza vaccination recipients who are reached with the intervention.
确定在高容量流感疫苗接种诊所为符合条件的患者提供家庭粪便免疫化学检测（FIT）是否可以提高管理式医疗环境中的结直肠癌筛查（CRCS）率。
观察性研究。
在 2008 年的流感疫苗接种诊所期间，经过培训的工作人员向符合 CRCS 条件的患者（FLU-FIT 组）（FLU 表示流感疫苗）提供 FIT。比较了这一组患者的筛查结果与未接受干预措施的类似流感诊所参与者（FLUonly 组）的结果。
在 FLUonly 组的合格参与者中（N = 4653），有 13.7％在接受流感疫苗后 90 天内完成了 FIT，而在 FLU-FIT 组（N = 2812）中，有 30.3％完成了 FIT（P <.0001）。在 FLU-FIT 组中，有 1447 名（51.4％）患者提供了 FIT 试剂盒，其中 653 名（45.1％）患者在 90 天内完成了 FIT 试剂盒。在多变量分析中，与 FLU-only 组参与者相比，FLU-FIT 组参与者完成 FIT 的可能性明显更高（优势比= 2.76 [95％置信区间，2.45-3.11]）。总体而言，与 FLU-only 组相比，FLU-FIT 组的 CRCS 率从 51.5％增加到 56.3％（增加了 4.8 个百分点），而从 49.2％增加到 63.2％（增加了 14.0 个百分点）（差异变化的 P 值<.0001）。
FLU-FIT 计划在管理式医疗环境中进行的高容量流感疫苗接种诊所中实施是可行的，并增加了接受干预措施的合格流感疫苗接种接受者的结直肠癌筛查活动。
